-
FDA clears first new hep B vaccine in 25 years
pharmatimes
November 14, 2017
The US Food and Drug Administration is allowing onto the market the first new hepatitis B vaccine in more than 25 years with the approval of Dynavax’ Heplisav-B.
-
Researchers design a vaccine for Streptococcus
biospectrumasia
November 07, 2017
The researchers say that a vaccine which was 80% effective and reached 90% of women could potentially prevent 231,000 infant and maternal cases of disease.
-
4-in-1 vaccine may provide lifelong protection against influenza
europeanpharmaceuticalreview
November 06, 2017
A vaccine combining centralised ancestral genes from four major influenza strains appears to provide broad protection against influenza…
-
China approves domestic Ebola vaccine
biospectrumasia
October 27, 2017
The newly approved vaccine is superior to the currently available vaccines in terms of the stability.
-
GSK's shingles vaccine scores US approval
pharmafile
October 24, 2017
GlaxoSmithKline has announced that its shingles vaccine Shingrix (Zoster Vaccine Recombinant, Adjuvanted) has been awarded FDA approval for the prevention of the disease in patients aged 50 or older.
-
New vaccine offers hope for pneumonia
europeanpharmaceuticalreview
October 23, 2017
Scientists are developing a vaccine by targeting strains of S. pneumoniae…
-
Lilly teams up with CureVac in $1.8 billion cancer vaccine partnership
pharmafile
October 20, 2017
Eli Lilly has announced it is to partner up with CureVac to leverage its proprietary RNActive technology in order to develop and commercialise up to five cancer vaccine products.
-
GlaxoSmithKline wins first-ever nod for blockbuster vaccine prospect Shingrix
fiercepharma
October 18, 2017
The Canadian approval covers people 50 years or older, as a prevention tool against the painful condition that's caused by latent varicella infection.
-
Kerala to manufacture anti-rabies vaccine
expressbpd
October 18, 2017
The vaccine for both humans and animals will be developed simultaneously at separate labs at the Institute of Animal Health and Veterinary Biologicals with an investment of Rs 150 crore
-
A Zika vaccine shows signs of success in an early human trial
biospectrumasia
October 10, 2017
The Inovio-GeneOne shot is a synthetic vaccine made by reproducing sections of the Zika virus genome in a lab.